Trusted Resource for Clinical Trials, Protocols & Progress
The purpose of this SOP is to establish the requirements for training of clinical research staff, including initial and ongoing training, to ensure compliance with Good Clinical Practice (GCP), applicable regulations, and study-specific requirements. Training ensures that staff are competent, compliant, and inspection-ready.
Click to read the full article.
The purpose of this SOP is to outline the process for evaluating training effectiveness and performing competency sign-off for clinical trial staff. This ensures that individuals are qualified, competent, and authorized to perform assigned trial-related tasks, thereby maintaining compliance with ICH GCP, FDA, EMA, CDSCO, and WHO requirements.
Click to read the full article.
The purpose of this SOP is to establish procedures for identifying, escalating, and addressing non-compliance in clinical trials through Corrective and Preventive Actions (CAPA). It ensures that deviations and violations are promptly managed to protect subject safety, maintain data integrity, and comply with global regulatory requirements.
Click to read the full article.
The purpose of this SOP is to define the process for effective Change Control Management in clinical research. Changes in systems, processes, vendors, and trial protocols must be controlled, documented, and approved to ensure compliance with ICH GCP, FDA, EMA, CDSCO, and WHO requirements. This SOP ensures changes are managed in a structured, risk-based, and traceable manner.
Click to read the full article.
The purpose of this SOP is to outline the procedures for clinical study closeout at both the site and sponsor levels. It ensures all regulatory, ethical, and operational requirements are met prior to study termination, including proper IP reconciliation, TMF/ISF finalization, subject follow-up, regulatory notifications, and archiving of study materials.
Click to read the full article.
The purpose of this SOP is to define the process for preparing the Final Clinical Study Report (CSR) according to ICH E3 guidelines and applicable regulatory requirements (FDA, EMA, CDSCO, WHO). The CSR provides a comprehensive, accurate, and transparent account of study objectives, methodology, conduct, results, and conclusions for regulatory and scientific audiences.
Click to read the full article.
The purpose of this SOP is to outline procedures for registering clinical trials and posting results in publicly accessible registries such as ClinicalTrials.gov, EU CTR/CTIS, and WHO ICTRP. This ensures regulatory compliance, promotes transparency, and supports global commitments to public disclosure of trial information.
Click to read the full article.
The purpose of this SOP is to outline the publication policy and disclosure/transparency practices for clinical trials. It ensures accurate, timely, and unbiased dissemination of trial results to regulatory agencies, investigators, participants, and the public while meeting global regulatory and ethical requirements.
Click to read the full article.
The purpose of this SOP is to define procedures for the secure and compliant sharing of clinical trial data with regulators and public repositories. Data sharing enhances transparency, facilitates regulatory review, and supports global scientific collaboration while protecting subject confidentiality.
Click to read the full article.
The purpose of this SOP is to define standardized procedures for the accountability, calibration, and maintenance of devices used in clinical trials. Proper management of devices ensures reliability of data, subject safety, regulatory compliance, and inspection readiness.
Click to read the full article.
